Menu Search
Equities

Jenscare Scientific Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
9877:HKG.HS

Jenscare Scientific Co Ltd

Actions
  • Price (HKD)7.88
  • Today's Change-0.01 / -0.13%
  • Shares traded4.40k
  • 1 Year change+87.62%
  • Beta0.8804
Data delayed at least 15 minutes, as of Feb 16 2026 04:08 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Jenscare Scientific Co Ltd is a China-based company mainly engaged in the research and development of interventional products for the treatment of structural heart diseases and other related medical products. The Company develops a series of treatment solutions targeting different types of structural heart diseases. The Company's products and pipelines mainly include LuX-Valve, LuX-Valve Plus, Ken-Valve, JensClip, JensRelive, MicroFlux and SimuLock. LuX-Valve is the transcatheter tricuspid valve replacement system designed to treat patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is the transcatheter aortic valve replacement system designed to treat patients with severe aortic regurgitation or combined with aortic stenosis.

  • Revenue in HKD (TTM)15.19m
  • Net income in HKD-276.96m
  • Incorporated2011
  • Employees174.00
  • Location
    Jenscare Scientific Co LtdBlock 5, B Area,No. 777 Binhai 4th Road, Hangzhou Bay NeNINGBO ChinaCHN
  • Websitehttps://www.jenscare.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.